Samuel Waxman is a partner in the Mergers and Acquisitions and Technology Transactions practices at Paul Hastings. He is based in the firm’s New York office.
Mr. Waxman’s practice focuses on mergers and acquisitions, securities offerings, joint ventures, and intellectual property licenses, with a particular emphasis on companies for whom technology or intellectual property is a key asset. He also represents venture investment funds and emerging technology companies, and is experienced in structuring and negotiating angel and venture financing. His clients range in size from Fortune 100 firms to emerging-stage companies in such diverse industries as pharmaceuticals, medical devices, data security, mobile devices, networking equipment and biotechnology. Mr. Waxman lectures on intellectual property licensing issues at Cornell Tech, the technology-focused campus of Cornell University located in New York City.
Venture Capital & Minority Investments
Mergers & Acquisitions and Joint Ventures
Deerfield Management and Johns Hopkins University Launch Early-Stage Therapeutics Research Collaboration
November 16, 2017
Broad Institute and Deerfield Management Form on Early-Stage Therapeutics Research Partnership
October 26, 2017
Phosplatin Therapeutics Announces Immuno-Oncology Collaboration with Pfizer and Merck KGaA, Darmstadt, Germany
September 13, 2017
Paul Hastings Recognized For Pristine Patent Litigation Track Record in 2017 IAM Patent 1000
August 08, 2017
Paul Hastings Practices and Lawyers Score Top Rankings in Chambers USA 2017
June 05, 2017
Paul Hastings Advises Intertrust on Launch of PatentShield
April 25, 2017
Legendary Golfer Greg Norman Partners with Authentic Brands Group
March 21, 2017
Elanco Animal Health Acquires Boehringer Ingelheim Vetmedica’s U.S. Feline, Canine and Rabies Vaccines Portfolio
January 03, 2017
Takeda Pharmaceutical Company, Bay City Capital and Deerfield Management Partner with Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine on Launch of Pioneering Drug Discovery Company Bridge Medicines
November 01, 2016
Elanco US Enters into Agreement to Acquire Boehringer Ingelheim Vetmedica’s U.S. Feline, Canine and Rabies Vaccine Portfolio for $885 Million
October 05, 2016
Merck and Quartet Enter Into Strategic Agreement
January 06, 2016
Paul Hastings Adds Prominent M&A and Private Equity Duo in Hong Kong
April 22, 2015
Paul Hastings Adds M&A/Technology Transactions Partner in New York
March 02, 2015
NYC: Municipal Benefactor to Life Sciences and Technology Venture Capital
November 21, 2017
Resigning From a Board of Directors: Considerations for VC Fund Designees
March 27, 2017
Venture Debt: An Attractive Tool for Startup Companies
February 02, 2017
Revisiting the CVR: The Litigation Crucible
November 15, 2016
Making the Grade: Negotiating IP Licenses with Academic Institutions
November 04, 2016
When Minority Stockholders Take Control: Recent Delaware Cases Shine a Light on Fiduciary Obligations of Controlling Stockholders
July 22, 2016
Post-Closing Fraud Claims in the Acquisition Context: Protecting the Seller
February 19, 2016
Solving The Valuation Puzzle in Life Sciences Transactions: The Pros and Cons of the CVR
January 26, 2016
Not Just Refrigerators and Light Bulbs: Connected Vehicles as an Extension of the Internet of Things
April 17, 2015
Paul Hastings IP Practice Honored in IAM Patent 1000
Intellectual Asset Management highlighted Paul Hastings' IP practice in IAM Patent 1000: The World's Leading Patent Professionals. The guide ranked the firm's practices Nationwide as well as in New York and Washington, DC.
Paul Hastings partners were ranked in California: Yar Chaikovsky; New York: Joseph O'Malley; Gerald Flattmann; Preston Ratliff; Bruce Wexler; Samuel Waxman; Washington DC: Naveen Modi; Blair Jacobs; Joseph Palys; and Allan Soobert; and in Japan: Hiroyuki Hagiwara.
Paul Hastings attorneys were also recognized in IAM's Nationwide tables: Yar Chaikovsky and Blair Jacobs were recommended for International Trade Commission litigation; Jacobs was recommended for his experience in Federal Circuit appellate litigation; and Naveen Modi and Joseph Palys were both recognized for their strength in post-grant proceedings.
Preston Ratliff was also noted in the IAM Strategy 300, which recognizes individuals for their work in protecting intellectual property as a key business asset.
Chambers USA 2017: America’s Leading Lawyers for Business
Chambers USA 2017: America’s Leading Lawyers for Business named 46 of the firm’s practice areas and 112 individuals to its ranking of leading lawyers and law firms in the United States.
June 05, 2017
Paul Hastings IP Practice Honored in 2016 IAM Patent 1000
Intellectual Asset Management highlighted Paul Hastings' IP practice in its IAM Patent 1000: The World’s Leading Patent Professionals 2016. The guide ranked the firm’s Nationwide, New York, Washington, D.C., and Georgia IP practices; and partners Yar Chaikovsky, Gerald Flattmann, Blair Jacobs, Robin McGrath, Naveen Modi, Joseph O'Malley, Joseph Palys, Preston Ratliff, Samuel Waxman, and Bruce Wexler were recognized as leading lawyers.
May 27, 2016